-

Aplantex’s 2025 Bridge Oversubscribed by +2M$

MONTREAL--(BUSINESS WIRE)--Aplantex highlights with satisfaction having exceeded its bridge financing target in 2025, closing at 5M$. "We are delighted that the relevance of our past, current, and planned strategic initiatives is recognized by the growing commitment of our early investors, including François Ravenelle, lead investor in this bridge round, and our main partners, led by Investissement Québec. This support energizes the Aplantex team. Ongoing R&D projects are on track to meet the requirements of our current national and international clients, and exciting new initiatives are designed to improve the efficiency of Aplantex’s unique green biotechnology process and reduce the selection time for relevant variations of our proprietary photosynthetic phytoreplicators. Our progression is gaining traction as the innovation center is expanding to include an industrial-grade pilot plant." Mr. Patrick Charest, B.Sc., Eng., mMBA, CEO.

This exciting upshot fuels Aplantex's progression from a research-focused company to a production-oriented company Ce résultat stimulant alimente la progression d'Aplantex d'une entreprise axée sur la recherche à une entreprise orientée vers la production

Share

"This bridge financing is an important step, allowing the company to pivot from a research-focused company to a production-oriented company, creating exciting new opportunities for the Company and for its growth," said François Ravenelle, Ph.D., Lead Investor and Aplantex Board member.

"Thanks to its biotechnology, Aplantex fully illustrates the potential of Quebec companies to develop innovative, high-value-added solutions for strategic industries, while reducing their environmental footprint. By supporting Aplantex through the Impulsion Fund, Investissement Québec contributes to the emergence of technologies that strengthen supply chains and accelerate the transition to more sustainable industrial models." Alex Laverdière, Vice President, Venture Capital, Investissement Québec.

About Aplantex

The scientific team at Aplantex has developed a unique process for the local production of high-value plant active ingredients, which respects the principles of the circular economy. The core of this green biotechnology process is the continuous production, in a controlled environment, of plant biomass from photosynthetic replicators of proprietary plants. This abundant biomass is then dried, and the extraction, fractionation, and purification steps allow us to isolate specific molecules essential to many flagship products of major players in the cosmetics, food additive, and nutritional health product industries.

For more information on Aplantex, visit: https://aplantex.ca

About Investissement Québec

Investissement Québec is Quebec's economic development agency. The company offers financing and support from its experts so that businesses can innovate, increase productivity, and export more. Its mission is to contribute to the growth of Quebec businesses, whether they are small, medium, or large, throughout the entire Quebec territory. As these businesses grow, they create wealth, jobs, and bring along their employees, their suppliers, the businesses in their regions, their communities, and Quebec as a whole.​

Investissement Québec offers financing in the form of loans and investments, in addition to administering certain government programs. In terms of support, its experts advise companies in their technological transformation, to diversify their export markets or establish themselves abroad, as well as providing business advice. Investissement Québec International also ensures the attraction of foreign investment to Quebec.

For more information, visit: www.investquebec.com

Contacts

Marc-André Ménard
450 531-2275
mamenard@aplantex.ca

Aplantex


Release Versions

Contacts

Marc-André Ménard
450 531-2275
mamenard@aplantex.ca

More News From Aplantex

A Joint Research Project With Université Laval Aims to Enable Aplantex to Increase Its Production of High-Value Molecules

MONTREAL--(BUSINESS WIRE)--“This research project, benefiting from a budget of $2.2 million, one of six jointly supported by Genome Canada and Génome Québec, aims to set up a high-throughput platform integrating genetic transformation, multi-omics analyses, and phenotype detection through hyperspectral imaging, using artificial intelligence, allowing for accelerated selection of clonal plant lines,” says Dr. Davoud Torkamaneh, assistant professor in the Department of Plant Science at the Facult...

Aplantex and Investissement Québec Team up to Produce Molecules for the Cosmetic and Food Industries

MONTREAL--(BUSINESS WIRE)--Aplantex and Investissement Québec are pleased to announce a partnership to boost the deployment of Aplantex's innovative green biotechnology. Under this partnership, Investissement Québec provides Aplantex access to its technological demonstration plant for sustainable chemistry in Québec City and to its technical innovation experts to increase its capacity to produce valuable plant-based molecules for the agri-food, pharmaceutical, cosmetic, and natural health indus...

Symrise and Aplantex Confirm an Agreement to Establish a Partnership

MONTREAL--(BUSINESS WIRE)--Symrise AG ("Symrise") and Aplantex Bio ("Aplantex") agree on a partnership covering new technologies for accessing plant-based molecules as raw material once the molecules of interest have been developed and produced by Aplantex. "We are intrigued by the potential of Aplantex’s innovative green biotechnology process to help us in securing potential access to hard-to-source plant-based molecules in the context of the significant impacts of climate change," underlines...
Back to Newsroom